The 61st Congress of the German Society of Urology
Dresden, Germany 16-19 September
Prostate cancer
Embracing Excellence in Prostate, Bladder and Kidney Cancer
Barcelona, Spain 26-29 November
Aktueller Stunde" zur PSA-gestützten Früherkennung des Prostatakarzinoms
PSA-Kritiker PD Dr. rer. nat. Hans-Hermann Dubben und DGU-Generalsekretär Prof. Dr. Michael Stöckle suchten das Gespräch Selten wurde zwischen den Kritikern und den Befürwortern der PSA-gestützten Früherkennung des Prostatakarzinoms so hart diskutiert. Die Veröffentlichung der randomisierten Studien zum PSA-Screening aus Europa (ERSPC-Studie) und den USA (PLCO-Screeningstudie) hatte in…
Intensity-modulated radiotherapy
IMRT is an evolving method of treatment for complex forms of cancer. Although patients benefit from treatment, a precise evaluation of that benefit and overall cost-effectiveness of the method is still an uncertain science. Mark Nicholls reports
Ultrasound-MRI fusion imaging
Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
Furthering education in Europe
Training is critical to the further development of urology across Europe, yet urologists recognise there are gaps in this; so much so that the European Society of Urological Technology (ESUT) has restructured with an emphasis on training to meet the demands and challenges ahead. Mark Nicholls reports.
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
Sonoelastography´s 2nd generation tools aid research
Current procedures are still imprecise and speculative; without a subsequent biopsy suspicious PSA levels, images and the results of palpation cannot be correctly evaluated. Thus there is an energetic pursuit to discover new imaging technologies. Dr Thilo Eggert at the Urological Clinic of the Ruhr University Bochum at the Marienhopital Herne, is among the investigators.
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
EAU hot topic: Imaging in urological oncology today
Big discussions are expected at the upcoming European Association of Urology (EAU) Congress in Stockholm* when urologist Dr Jochen Walz (right), of the Urological Department at the Institute Paoli-Calmettes, Marseilles, France, presents the forum: Imaging in Europe: Who, where, what, how many! and M F Coelho, of the European Society of Urological Imaging (ESUI) describes the Clinical utility of…
First prostate cancer biomarker identified in urine
A potential biomarker for cancer has been identified in urine.
GE's new Discovery PET/CT 600 scanners go global
GE Healthcare's first Discovery PET/CT 600-series scanners are being installed in a number of leading clinics around the world. "This first set of installations is a big step forward in the diagnosis and monitoring of disease", said Terri Bresenham, newly appointed vice- president and general manager of GE Healthcare's global Molecular Imaging business.
UROLOGY
17-21 March Stockholm Sweden
MANAGEMENT
Accreditation and standards of Excellence in Europe
Prostate Cancer Screening
We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
The PCA3 test
The number of prostate cancer cases is increasing rapidly.
The European Cancer Therapy Market
Cancer may well surpass cardiovascular diseases as the primary case of death in Europe by 2012. To prevent this from happening, cancer therapeutics have to shift in focus from the treatment of symptoms to offering a total cure, despite the complex, multifactorial nature of cancer indications.
Tele-oncology proves successful in Canada
An estimated 6.7 million people in developed countries were diagnosed with cancer in 2007. Delivering their care is no easy matter. Tele-oncology, the remote provision of oncology services, could not only reduce the costs of consultations for cancer departments, but also for patients. Kerry Heacox, of i.t. Communications, reports on the success of remote consultations in Labrador and Newfoundland.…
US oncology expertise to spread globally
The University of Pittsburgh Medical Center and GE Healthcare plan to establish over 25 local cancer centres in various countries within the coming decade.
In vivo biopsy for histological analysis
Early suspicions of cancer, either from clinical evidence or medical imaging, are often followed up on biopsy. However, the removal of tissue for histological analysis can be uncomfortable for patients.
Prostate cancer: Urine test instead of biopsy?
Currently, early detection of Prostate Cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample.
Sono-elastography
Martini Clinic, in the University Hospital Eppendorf (UKE) campus in Hamburg, is one of the world's major centres for nerve-sparing prostatectomy. The Martini physicians not only specialise in surgical intervention but are also at the cutting edge of diagnostics, being among the few in Germany to use sono-elastography, an innovative tool to detect prostate cancer. We asked Dr Georg Salomon (GS),…
Laparoscopy in urology
Laparoscopy is playing an increasingly important role in urology and centres of excellence have been established to provide training in urological laparoscopic surgery.
Robot-assisted prostatectomy in practical use
At the Medizin Innovativ 2008 congress (9-10 July, Nuremburg, Germany) Professor Jens-Uwe Stolzenburg MD (right), Director of the Urology Clinic and Polyclinic at the University Hospital Leipzig, talked about his experiences with the da Vinci robot. Used by surgeons at University Hospital Leipzig since last October 2007, they performed 40 operations in the first two months.